Uracle

Total Valuation

Uracle carries a market capitalization of 27.24B, placing it among publicly traded companies globally. Its enterprise value stands at 43.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Valuation Ratios

The price-to-sales ratio is 1.10, and the price-to-book ratio stands at 6.16.

Enterprise Valuation

Financial Position

Uracle maintains a current ratio of 3.88, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 26.29, indicating elevated leverage, while an interest coverage ratio of -69.89 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Uracle's stock has declined approximately -66.60241% over the past 52 weeks. The 50-day moving average sits at 10,036.20, while the 200-day moving average is 13,153.45.

Income Statement

Over the trailing twelve months, Uracle generated 40.80B in revenue and converted that into -6.73B in net income, yielding earnings per share of -1,712.09. EBITDA reached -6.59B, while operating income came in at -6.59B.

Balance Sheet

Uracle holds 5.97B in cash and equivalents against 4.89B in total debt, resulting in a net debt position of -5.27B. Total book value stands at 7.29B, with working capital of 15.72B providing operational flexibility.

Cash Flow

Uracle produced -6.98B in operating cash flow over the past twelve months. After subtracting -2.82B in capital expenditures, free cash flow totaled -9.81B - equivalent to -2,494.81 per share.

Margins

Uracle operates with a gross margin of 15.71, reflecting its pricing power and cost economics. The operating margin of -16.16 and net profit margin of -16.49 provide insight into operational efficiency.

Dividends & Yields

Scores

Uracle posts an Altman Z-Score of 3.34, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.